Stratos Wealth Partners, Ltd. Ionis Pharmaceuticals Inc Transaction History
Stratos Wealth Partners, Ltd.
- $6.9 Billion
- Q4 2024
A detailed history of Stratos Wealth Partners, Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 12,813 shares of IONS stock, worth $397,715. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,813
Previous 12,788
0.2%
Holding current value
$397,715
Previous $512,000
12.7%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
841KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$511 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$440 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$356 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$320 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$269 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.41B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...